andexanet
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Learning Objectives: Factor Xa inhibitors have gained popularity over vitamin K antagonists (VKAs) over the past years due to…
Direct oral anticoagulants are becoming increasingly popular in outpatient use. These medications have lacked specific reversal…
Recently, a study about andexanet for reversal of bleeding associated with factor Xa inhibitors has been published [1]. In this…
Venous thromboembolism (VTE) is associated with significant morbidity and mortality. Factors such as the presence of transient…
This update reviews articles on nonmalignant hematology, malignant hematology, and medical oncology that were published in 2016…
Until late 2010, the vitamin K antagonist warfarin was the only oral anticoagulant approved in the United States for the…
Bleeding is a potential complication with factor Xa inhibitors, but two studies reported in the New England Journal of Medicine…
Portola's andexanet alfa and Boehringer Ingelheim's idarucizumab are both due to be filed for approval this year, with big…